Rapamycin-induced extracellular vesicles and application thereof in preparation of drugs for promoting wound repair
Through rapamycin-induced extracellular vesicles inhibit macrophage function, promote endothelial cell migration and duct formation, activate the PI3K/Akt signaling pathway, solve the problem of poor healing in diabetic wounds and achieve rapid wound repair.
Patent Information
- Application Number
- CN202510520364.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-04-24
- Publication Date
- 2025-07-25
AI Technical Summary
Poor healing and pathological healing of diabetic wounds are clinical problems, and the prior art is difficult to effectively promote angiogenesis and alleviate macrophage-mediated inflammatory responses.
Using rapamycin-induced extracellular vesicles, by inhibiting the proliferation and migration of macrophages, promote endothelial cell migration and tube formation, activate the PI3K/Akt signaling pathway, accelerate angiogenesis, and prepare drugs to promote wound repair.
Extracellular vesicles induced by rapamycin can effectively inhibit the expression of pro-inflammatory mediators in macrophages, promote endothelial cell migration and tube formation, increase VEGF levels, reduce inflammatory responses, and promote rapid healing of diabetic wounds.